Newsletter registration

Австрия
Мост к новым рынкам

Merck invests EUR 7.6 million

Two billion tablets

“This comprises the largest single investment in the history of Merck Spittal“, says Klaus Raunegger, Managing Director of Merck in Spittal. The site has long become a showcase plant within the Merck Group of Germany. Four of the company’s eight most important brands on the global market are manufactured in Carinthia. “Over the last ten years the number of packs of medicine produced here has increased five-fold, from 14 million to 70 million. The volume of tablets manufactured in Spittal has climbed from 400 million to 1.3 billion”, Raunegger explains.  More than 90 percent of the medication is destined for export. In 2018, the “competence center” in Spittal is expected to manufacture about two billion tablets annually. The plant produces, amongst other products, various over the counter vitamin products and food supplements, nose sprays (Nasivin) and pain relief creams. The production of “Vigantoletten” (Vitamin D) is being transferred from Darmstadt to Spittal within the context of the expansion program.  Quality control also takes place at the Carinthian facility. Production volume has risen four-fold overall during the last ten years. 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter

Отзывы

Мероприятия

Познакомьтесь с нами в рамках мероприятий, семинаров и выставок по всему миру

Austria Map

Find the perfect location for your company

Австрия занимает ключевую позицию для бизнеса между Востоком и Западом. Мы высоко ценим превосходную инфраструктуру, в особенной мере отличное воздушное сообщение, высококвалифицированные трудовые кадры, а также первоклассное качество жизни в Вене.

ЛУКОЙЛ

Lukoil Logo
Все отзывы

Новости Австрии, как площадки для бизнеса

Jaguar E-Pace rolls off the assembly lines in Austria

The new Jaguar SUV named E-Pace is being manufactured by Magna in Graz, the second vehicle of the British producer to be assembled in Austria.

Testing the potential early detection of ovarian cancer

About 75 percent of the cases of extremely aggressive ovarian cancer (ovarian carcinoma) originally arise in the fallopian tube. Currently there are no possibilities to detect this at an early stage. A new catheter system developed by Viennese scientists could represent a new possibility to deal with this.

Все новости